The companies would agree to align prices on outpatient drugs for state Medicaid programs with what they charge in foreign countries

The companies would agree to align prices on outpatient drugs for state Medicaid programs with what they charge in foreign countries

The Trump administration is expected to announce voluntary drug-pricing agreements with midsize biotech companies, requiring discounts for outpatient medicines supplied through…